Inclusion of Thiotepa in Myeloablative Regimens Improves Donor Chimerism in Children with Inborn Errors of Immunity or Inherited Metabolic Disorders
Original data are available upon reasonable request from the corresponding author, Caitlyn McComb. Email: [email protected]. Table S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Rolla Abu‐Arja (ORCID: https://orcid.org/0000-0001-9768-7520)
- Rajinder Bajwa (ORCID: https://orcid.org/0000-0003-4498-0322)
- Alexander W. Rankin (ORCID: https://orcid.org/0000-0002-6089-9279)
- Nabanita Bhunia (ORCID: https://orcid.org/0000-0001-6068-5783)
- Hemalatha G. Rangarajan (ORCID: https://orcid.org/0000-0003-3371-2920)
- Caitlyn McComb
- Vinita Pai
- Margaret Lamb
- Joseph Stanek
Institutions
- Nationwide Children's Hospital (US)
- The Ohio State University (US)
Publication Details
- Journal
- British Journal of Haematology
- Published
- 2026-04-15
- DOI
- https://doi.org/10.1111/bjh.70486
- Primary Topic
- Neurogenetic and Muscular Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00